Concepedia

George Wilding

GW

Statistics

Publications

241

Citations

31.9K

H-Index

80

Active since

1977

Affiliations

University of Wisconsin Carbone Cancer Center(Current)

University of Wisconsin–Madison

Spanish Oncology Genitourinary Group

Dana-Farber Cancer Institute

Memorial Sloan Kettering Cancer Center

George Wilding is an author at University of Wisconsin Carbone Cancer Center specializing in medicine, oncology, and pharmacology.

Publications per year

1977–2024

241

Publications

241

Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

Howard I. Scher, Susan Halabi, Ian F. Tannock et al. · Journal of Clinical Oncology · 2008 · 2.2K citations · Full text

Medicine, Oncology, Urology +17

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

Robert J. Motzer, Thomas E. Hutson, Piotr Tomczak et al. · Journal of Clinical Oncology · 2009 · 2.2K citations

Medicine, Oncology, Pharmacology +13

Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma

Robert J. Motzer, M. Dror Michaelson, Bruce G. Redman et al. · Journal of Clinical Oncology · 2005 · 1.6K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

Howard I. Scher, Michael J. Morris, Walter M. Stadler et al. · Journal of Clinical Oncology · 2016 · 1.6K citations

Medicine, Oncology, Urology +17

Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Robert J. Motzer, Brian I. Rini, Ronald M. Bukowski et al. · JAMA · 2006 · 1.2K citations

Medicine, Oncology, Pharmacology +17

1–5 of 241